Cidara Therapeutics Inc (CDTX) - Financial and Strategic SWOT Analysis Review



Cidara Therapeutics Inc (Cidara), formerly K2 Therapeutics Inc is a biotechnology company that discovers, develops and commercializes novel anti-infectives including immunotherapies. The companys pipeline products include CD101 for treatment of invasive fungal disease; and CD377 for treating influenza. The company is investigation RSV AVC program for treatment of respiratory syncytial virus (RSV); HIV AVC for human immunodeficiency viruses (HIV); CoV AVC for pan corona virus. Cidara proprietary Cloudbreak, an antiviral platform to the fight against life-threatening infectious disease that provides potent antiviral activity and immune system engagement in a single molecule. The company works in collaboration with Mundipharma International Ltd to develop and commercialize rezafungin for the treatment and prevention of invasive fungal disease. Cidara is headquartered in San Diego, California, the US.

Cidara Therapeutics Inc Key Recent Developments

May 13,2020: Cidara provides corporate update and reports first quarter 2020 financial results
May 05,2020: Others : Cidara Therapeutics Announces New Clinical and Preclinical Data for Rezafungin and Influenza AVCs from the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
May 05,2020: Others : Cidara Therapeutics Announces New Clinical and Preclinical Data for Rezafungin and Influenza ...
Mar 04,2020: Cidara Therapeutics provides corporate update and reports fourth quarter and full year 2019 financial results
Nov 18,2019: Cidara Therapeutics named a San Diego Metro Area Top Workplace for the Third Consecutive Year

This comprehensive SWOT profile of Cidara Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Cidara Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,


- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
 



Section 1 - About the Company

Cidara Therapeutics Inc - Key Information
Cidara Therapeutics Inc - Overview
Cidara Therapeutics Inc - Key Employees
Cidara Therapeutics Inc - Key Employee Biographies
Cidara Therapeutics Inc - Key Operational Heads
Cidara Therapeutics Inc - Major Products and Services
Cidara Therapeutics Inc - History
Cidara Therapeutics Inc - Company Statement
Cidara Therapeutics Inc - Locations And Subsidiaries
Cidara Therapeutics Inc
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Cidara Therapeutics Inc - Business Description
Cidara Therapeutics Inc - Corporate Strategy
Cidara Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Cidara Therapeutics Inc - Strengths
Cidara Therapeutics Inc - Weaknesses
Cidara Therapeutics Inc - Opportunities
Cidara Therapeutics Inc - Threats
Cidara Therapeutics Inc - Key Competitors

Section 3 - Company Financial Performance Charts

Cidara Therapeutics Inc - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company
 


List Of Tables



Cidara Therapeutics Inc, Key Information
Cidara Therapeutics Inc, Key Ratios
Cidara Therapeutics Inc, Share Data
Cidara Therapeutics Inc, Major Products and Services
Cidara Therapeutics Inc, History
Cidara Therapeutics Inc, Key Employees
Cidara Therapeutics Inc, Key Employee Biographies
Cidara Therapeutics Inc, Key Operational Heads
Cidara Therapeutics Inc, Other Locations
Cidara Therapeutics Inc, Subsidiaries
Cidara Therapeutics Inc, Key Competitors
Cidara Therapeutics Inc, SWOT Analysis
Cidara Therapeutics Inc, Ratios based on current share price
Cidara Therapeutics Inc, Annual Ratios
Cidara Therapeutics Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
 


List Of Figures



Cidara Therapeutics Inc, Performance Chart
Cidara Therapeutics Inc, Ratio Charts
 


Anika Therapeutics Inc (ANIK) - Product Pipeline Analysis, 2021 Update

Anika Therapeutics Inc (Anika) develops, manufactures, and markets therapeutic products for degenerative orthopedic diseases and traumatic conditions. It offers solutions for ortho-biologics, dermal, ophthalmic, surgical and veterinary applications. Its major

USD 750 View Report

Chinook Therapeutics Inc (KDNY) - Financial and Strategic SWOT Analysis Review

Chinook Therapeutics, Inc (Chinook)., formerly Aduro BioTech Inc is a clinical-stage immunotherapy company that discovers, develops and commercializes therapies for the treatment of cancer. The company develops product candidates using

USD 300 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available